Evidence map›Paper›PMID 41971435›Full record

ArticleFrontiers in oncology2026

Integrated ultrasound-based radiomics and deep learning models in screening breast intraductal high-risk lesions or carcinoma: a multicenter retrospective study.

Na Li, RuiJiao Chang, Bo Jiang, Xin He, FengSheng Li, YongXin Li, SanLi Guan, Jun Lian

Abstract read
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Na LiDepartment of Ultrasound, The 4th (Xing Yuan) Hospital of Yulin, Yulin, Shaanxi, China.
RuiJiao ChangDepartment of Ultrasound of the General Hospital of Ningxia Medical University, Yinchuan, Ningxia Hui Autonomous Region, China.
Bo JiangDepartment of ultrasound, The First Medical Centre, Chinese PLA General Hospital, Beijing, China.
Xin HeDepartment of Ultrasound, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
FengSheng LiDepartment of Ultrasound of the Xi'an Gaoxin Hospital, Xi 'an, Shaanxi, China.
YongXin LiSchool of Automation and Intelligence, Beijing Jiaotong University, Beijing, China.
SanLi GuanDepartment of Ultrasound, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Jun LianDepartment of Ultrasound, Ankang Central Hospital, Ankang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: The aim of this study was to explore the diagnostic performance of ultrasound (US)-based radiomics combined with deep learning (DL) in the screening of high-risk and malignant intraductal breast lesions. Methods: This multicenter retrospective study included patients with breast intraductal lesions from January 2022 to June 2024 from five hospitals in China. In the training set, conventional US images were segmented and radiomics features were extracted. After feature selection using least absolute shrinkage and selection operator (LASSO) regression, a radiomics model was developed using logistic regression, and the DL model was constructed based on ResNet-50. An integrated model was constructed by fusing the predicted probabilities from single models. The diagnostic performance of US, radiomics, DL, and integrated models was compared in the internal and external validation sets. Results: A total of 785 lesions were collected, including 486 benign lesions and 299 high-risk or malignant lesions. In the training set (520 lesions), the integrated model achieved superior performance (area under the curve (AUC) = 0.946 [0.923, 0.964]) to that of the US model (AUC = 0.774 [0.732, 0.816]; Conclusion: The integrated radiomics and DL model demonstrated potential clinical value in screening the high-risk or malignant breast intraductal lesions.

Indexed as

breast intraductal lesiondeep learningmulticenter studyradiomicsultrasound

Identifiers

PMID41971435
PMCPMC13061718

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.